Xgeva 120 MG/1.7 ML vial 1.7ML
Ended Awarded Last action
- Contract number
- SPE2DR26FQU2Y
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $37,049
Award facts
- Contract value 100% obligated
- $37,049.19 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $37,049.19 firm fixed-price delivery order to Amerisourcebergen Drug Corp (UEI: KABZK8W6PQT3) on January 12, 2026, for the supply of XGEVA 120 mg/1.7 mL vials. The contract, which carries an ultimate completion date of January 13, 2026, represents a non-set-aside competitive award with performance to occur at the contractor's facility in Conshohocken, Pennsylvania. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. (doing business as Amerisourcebergen), a major pharmaceutical distributor serving federal government healthcare systems.
This delivery order is issued under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at up to $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities. The firm's extensive contract portfolio with DLA demonstrates its capability to meet federal medical procurement requirements through open competition across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FQU2Y?
SPE2DR26FQU2Y was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26FQU2Y worth?
The government has obligated $37,049 on SPE2DR26FQU2Y.
Is contract SPE2DR26FQU2Y an order under another contract?
Yes. SPE2DR26FQU2Y is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQU2Y competed?
The extent of competition for SPE2DR26FQU2Y was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award